AIG
APRE icon

American International Group’s Aprea Therapeutics APRE Stock Holding History

American International Group’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-210
Closed -$21 – 3109
2021
Q1 		$21 Buy
210
+1
+0.5% +$117 ﹤0.01% 3118
2020
Q4 		$21 Sell
209
-6
-3% -$2.85K ﹤0.01% 3086
2020
Q3 		$103K Sell
215
-5
-2% -$2.8K ﹤0.01% 2521
2020
Q2 		$171K Buy
220
+29
+15% +$19K ﹤0.01% 2213
2020
Q1 		$133K Sell
191
-11
-5% -$8.07K ﹤0.01% 2141
2019
Q4 		$186K Buy
+202
New +$111K ﹤0.01% 2265

Other funds holding APRE

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return

American International Group's APRE Position: Q2 2021 in Review

American International Group sold out of Aprea Therapeutics (APRE) in Q2 2021, closing a stake of 210 shares — an estimated $21 sold.

American International Group first reported a position in APRE in Q4 2019 and held it in 6 quarters. The position peaked at $186K in Q4 2019. 50 funds tracked by Wall St. Rank hold APRE as of Q2 2021.

  • American International Group reported no remaining Aprea Therapeutics position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 210 Aprea Therapeutics shares in Q2 2021, an estimated $21.
  • American International Group first reported a position in Aprea Therapeutics in Q4 2019 and held it in 6 quarters.
  • American International Group's Aprea Therapeutics position peaked at $186K in Q4 2019.
  • 50 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.